litlas
Log inCreate account

Alexander Gallus

Active 1969–2019

56
Papers
20,636
Citations
54
h-index
56
i10-index

Citations

Citations per year for Alexander Gallus1972: 3 citations1973: 7 citations1974: 9 citations1975: 9 citations1976: 10 citations1977: 17 citations1978: 10 citations1979: 15 citations1980: 10 citations1981: 9 citations1982: 21 citations1983: 11 citations1984: 6 citations1985: 16 citations1986: 17 citations1987: 8 citations1988: 11 citations1989: 16 citations1990: 24 citations1991: 16 citations1992: 47 citations1993: 34 citations1994: 32 citations1995: 34 citations1996: 38 citations1997: 31 citations1998: 63 citations1999: 43 citations2000: 37 citations2001: 50 citations2002: 29 citations2003: 54 citations2004: 63 citations2005: 62 citations2006: 62 citations2007: 61 citations2008: 88 citations2009: 69 citations2010: 105 citations2011: 107 citations2012: 133 citations2013: 174 citations2014: 158 citations2015: 138 citations2016: 123 citations2017: 115 citations2018: 103 citations2019: 430 citations2020: 409 citations2021: 314 citations2022: 210 citations2023: 166 citations2024: 295 citations2025: 85 citations2026: 11 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,209 citing papers, 23.7% of this breakdownCanada: 560 citing papers, 11% of this breakdownUnited Kingdom: 406 citing papers, 8% of this breakdownItaly: 292 citing papers, 5.7% of this breakdownGermany: 288 citing papers, 5.7% of this breakdownNetherlands: 234 citing papers, 4.6% of this breakdownChina: 225 citing papers, 4.4% of this breakdownFrance: 222 citing papers, 4.4% of this breakdownAustralia: 150 citing papers, 2.9% of this breakdownSwitzerland: 138 citing papers, 2.7% of this breakdownSpain: 121 citing papers, 2.4% of this breakdownJapan: 94 citing papers, 1.8% of this breakdown
0%23.7%Other 22.7%

Institutions

Fields

  • Medicine89.7%
  • Biochemistry, Genetics and Molecular Biology2.9%
  • Computer Science1.3%
  • Pharmacology, Toxicology and Pharmaceutics1.2%
  • Engineering1.1%
  • Immunology and Microbiology1%
  • Other2.8%

Topics

  • Venous Thromboembolism Diagnosis and Management22.8%
  • Atrial Fibrillation Management and Outcomes14%
  • Blood Coagulation and Thrombosis Mechanisms7.1%
  • Heparin-Induced Thrombocytopenia and Thrombosis5.2%
  • Antiplatelet Therapy and Cardiovascular Diseases2.6%
  • Acute Myocardial Infarction Research2.3%
  • Other46%

Coauthors

All papers

Open in search
  1. Thrombosis

    Authors: Gary E. Raskob, Pantep Angchaisuksiri, A Blanco, Harry R. Büller, Alexander Gallus, B. J. Hunt, Elaine M. Hylek, A. K. Kakkar, Stavros Konstantinides, Micah McCumber, Yukio Ozaki, Aaron M. Wendelboe, J Weitz - Arteriosclerosis Thrombosis and Vascular Biology 2014 cited by 1,143

  2. Oral Apixaban for the Treatment of Acute Venous Thromboembolism

    Authors: Giancarlo Agnelli, Harry R. Büller, Alexander T. Cohen, Madelyn Curto, Alexander Gallus, Margot Johnson, Urszula Masiukiewicz, Raphael Pak, John R. Thompson, Gary E. Raskob, Jeffrey I. Weitz - New England Journal of Medicine 2013 cited by 2,283

  3. Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism

    Authors: Timothy Brighton, John W. Eikelboom, K. Mann, Rebecca Mister, Alexander Gallus, Paul Ockelford, Harry Gibbs, Wendy Hague, Denis Xavier, Rafael Dı́az, Adrienne Kirby, John Simes - New England Journal of Medicine 2012 cited by 559

  4. Apixaban for Extended Treatment of Venous Thromboembolism

    Authors: Giancarlo Agnelli, Harry R. Büller, Alexander T. Cohen, Madelyn Curto, Alexander Gallus, Margot Johnson, Anthony R. Porcari, Gary E. Raskob, Jeffrey I. Weitz - New England Journal of Medicine 2012 cited by 1,341

  5. Oral Anticoagulant Therapy

    Authors: Walter Ageno, Alexander Gallus, Ann K. Wittkowsky, Mark Crowther, Elaine M. Hylek, Gualtiero Palareti - CHEST Journal 2012 cited by 1,503

  6. Thrombosis: a major contributor to the global disease burden

    Authors: Gary E. Raskob, Pantep Angchaisuksiri, A Blanco, Harry R. Büller, Alexander Gallus, Beverley J. Hunt, Elaine M. Hylek, A. K. Kakkar, Stavros Konstantinides, Micah McCumber, Yukio Ozaki, Aaron M. Wendelboe, Jeffrey I. Weitz - Journal of Thrombosis and Haemostasis 2014 cited by 481

  7. Thrombosis: A major contributor to global disease burden

    Authors: Gary E. Raskob, Pantep Angchaisuksiri, A Blanco, Harry R. Büller, Alexander Gallus, B. J. Hunt, Elaine M. Hylek, A. K. Kakkar, Stavros Konstantinides, Micah McCumber, Yukio Ozaki, Aaron M. Wendelboe, J Weitz - Thrombosis Research 2014 cited by 300

  8. Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement

    Authors: Michael R. Lassen, Alexander Gallus, Gary E. Raskob, Graham F. Pineo, Dalei Chen, Luz M. Ramirez - New England Journal of Medicine 2010 cited by 775

  9. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial

    Authors: Michael R. Lassen, Gary E. Raskob, Alexander Gallus, Graham F. Pineo, Dalei Chen, Philip Hornick - The Lancet 2010 cited by 777

  10. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial

    Authors: Alexander T Cohen, Bruce L. Davidson, Alexander Gallus, Michael R. Lassen, Martin H. Prins, Witold Tomkowski, Alexander G.G. Turpie, Jan F M Egberts, Anthonie W.A. Lensing - BMJ 2006 cited by 861

  11. Apixaban or Enoxaparin for Thromboprophylaxis after Knee Replacement

    Authors: Michael R. Lassen, Gary E. Raskob, Alexander Gallus, Graham F. Pineo, Dalei Chen, Ronald J. Portman - New England Journal of Medicine 2009 cited by 694

  12. A Prospective Study of the Value of Monitoring Heparin Treatment with the Activated Partial Thromboplastin Time

    Authors: Dilip Basu, Alexander Gallus, Jack Hirsh, J. F. Cade - New England Journal of Medicine 1972 cited by 670

  13. The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacement

    Authors: Michael R. Lassen, Bruce L. Davidson, Alexander Gallus, Graham F. Pineo, Jack Ansell, David Deitchman - Journal of Thrombosis and Haemostasis 2007 cited by 370

  14. Thrombosis: A Major Contributor to Global Disease Burden

    Authors: Pantep Angchaisuksiri, A Blanco, Harry R. Büller, Alexander Gallus, Beverley J. Hunt, Elaine M. Hylek, The Kakkar, Stavros Konstantinides, Micah McCumber, Yukio Ozaki, Aaron M. Wendelboe, Jeffrey I. Weitz, Gary E. Raskob, ; ISTH Steering Committee for World Thrombosis Day - Seminars in Thrombosis and Hemostasis 2014 cited by 143

  15. Deep-vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography

    Authors: Franco Piovella, Chin‐Wan Wang, Hao Lü, K. Lee, L. H. Lee, Wonkyung Lee, Alexander G.G. Turpie, Alexander Gallus, A. Planès, R. Passera, A. Rouillon - Journal of Thrombosis and Haemostasis 2005 cited by 206

  16. Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial

    Authors: Giancarlo Agnelli, H.R. Büller, Alexander Cohen, Alexander Gallus, T.C. Lee, Raphael Pak, Gary E. Raskob, Jeffrey I. Weitz, T. Yamabe - Journal of Thrombosis and Haemostasis 2015 cited by 196

  17. Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement

    Authors: Gary E. Raskob, Alexander Gallus, Graham F. Pineo, Dongyang Chen, L-M. Ramirez, Richard T. Wright, Michael R. Lassen - Journal of Bone and Joint Surgery - British Volume 2012 cited by 98

  18. Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home

    Authors: Maria M.W. Koopman, Paolo Prandoni, Franco Piovella, Paul Ockelford, Desiderius P.M. Brandjes, Jan van der Meer, Alexander Gallus, Gérald Simonneau, Colin Chesterman, Martin H. Prins, Patrick M. Bossuyt, Hanneke de Haes, A.G.M. van den Belt, Luc Sagnard, Pascal d’Azemar, Harry R. Büller - New England Journal of Medicine 1996 cited by 1,120

  19. Fondaparinux or Enoxaparin for the Initial Treatment of Symptomatic Deep Venous Thrombosis

    Authors: Harry R. Büller, Bruce L. Davidson, Hervé Decousus, Alexander Gallus, Michael Gent, Franco Piovella, Martin H. Prins, Gary Raskob, Annelise E.M. Segers, Roger Cariou, Oscar Leeuwenkamp, Anthonie W.A. Lensing, and The Matisse Investigators* - Annals of Internal Medicine 2004 cited by 616

  20. A Synthetic Pentasaccharide for the Prevention of Deep-Vein Thrombosis after Total Hip Replacement

    Authors: Alexander G.G. Turpie, Alexander Gallus, J. A. van den Hoek - New England Journal of Medicine 2001 cited by 380

  21. Incidence of Venous Thromboembolism in Asian Populations: A Systematic Review

    Authors: Lai Lee, Alexander Gallus, Ravul Jindal, Chen Wang, Chau-Chung Wu - Thrombosis and Haemostasis 2017 cited by 187

  22. Trial of Different Intensities of Anticoagulation in Patients with Prosthetic Heart Valves

    Authors: Jalal Saour, Jens O. Sieck, Layla Abdul Rahim Mamo, Alexander Gallus - New England Journal of Medicine 1990 cited by 371

  23. A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein–DVT Dose-Ranging Study

    Authors: Harry R. Büller, Anthonie W.A. Lensing, Martin H. Prins, Giancarlo Agnelli, Alexander T. Cohen, Alexander Gallus, Frank Misselwitz, Gary E. Raskob, Sebastian Schellong, Annelise Segers - Blood 2008 cited by 345

  24. Treatment of Proximal Deep-Vein Thrombosis With the Oral Direct Factor Xa Inhibitor Rivaroxaban (BAY 59-7939)

    Authors: Giancarlo Agnelli, Alexander Gallus, Samuel Z. Goldhaber, Sylvia Haas, Menno V. Huisman, Russel Hull, Ajay K. Kakkar, Frank Misselwitz, Sebastian Schellong - Circulation 2007 cited by 340